Literature DB >> 21483626

Patterns of local recurrence in rectal cancer after a multidisciplinary approach.

Jose M Enríquez-Navascués1, Nerea Borda, Aintzane Lizerazu, Carlos Placer, Jose L Elosegui, Juan P Ciria, Adelaida Lacasta, Luis Bujanda.   

Abstract

Improvements in surgery and the application of combined approaches to fight rectal cancer have succeeded in reducing the local recurrence (LR) rate and when there is LR it tends to appear later and less often in isolation. Moreover, a subtle change in the distribution of LRs with respect to the pelvis has been observed. In general terms, prior to total mesorectal excision the most common LRs were central types (perianastomotic and anterior) while lateral and posterior forms (presacral) have become more common since the growth in the use of combined treatments. No differences have been reported in the current pattern of LRs as a function of the type of approach used, that is, neo-adjuvant therapies (short-term or long-course radiotherapy, or chemoradiotherapy versus extended lymphadenectomy, though there is a trend towards posterior or presacral LR in patients in the Western world and lateral LR in Asia. Nevertheless, both may arise from the same mechanism. Moreover, as well as the mode of treatment, the type of LR is related to the height of the initial tumor. Nowadays most LRs are related to the advanced nature of the disease. Involvement of the circumferential radial margin and spillage of residual tumor cells from lymphatic leakage in the pelvic side wall are two plausible mechanisms for the genesis of LR. The patterns of pelvic recurrence itself (pelvic subsites) also have important implications for prognosis and are related to the potential success of salvage curative approach. The re-operability for cure and prognosis are generally better for anastomotic and anterior types than for presacral and lateral recurrences. Overall survival after LR diagnosis is lower with radio or chemoradiotherapy plus optimal surgery approaches, compared to optimal surgery alone.

Entities:  

Keywords:  Local neoplasm recurrence pelvis; Pattern of recurrence multidisciplinary approach; Rectal cancer

Mesh:

Year:  2011        PMID: 21483626      PMCID: PMC3072630          DOI: 10.3748/wjg.v17.i13.1674

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  75 in total

1.  Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.

Authors:  Miranda Kusters; Raphaëla C Dresen; Hendrik Martijn; Grard A Nieuwenhuijzen; Cornelis J H van de Velde; Hetty A van den Berg; Regina G H Beets-Tan; Harm J T Rutten
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-22       Impact factor: 7.038

2.  Locally recurrent rectal cancer in Norway.

Authors:  M H Hansen; L Balteskard; L M Dørum; M T Eriksen; B Vonen
Journal:  Br J Surg       Date:  2009-10       Impact factor: 6.939

Review 3.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

4.  Multicentre experience with extralevator abdominoperineal excision for low rectal cancer.

Authors:  N P West; C Anderin; K J E Smith; T Holm; P Quirke
Journal:  Br J Surg       Date:  2010-04       Impact factor: 6.939

5.  Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer.

Authors:  Yukihide Kanemitsu; Takashi Hirai; Koji Komori; Tomoyuki Kato
Journal:  Dis Colon Rectum       Date:  2010-05       Impact factor: 4.585

6.  Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis.

Authors:  Byung Soh Min; Jin Soo Kim; Nam Kyu Kim; Joon-Seok Lim; Kang Young Lee; Chang Hwan Cho; Seung Kook Sohn
Journal:  Ann Surg Oncol       Date:  2009-09-18       Impact factor: 5.344

7.  A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer.

Authors:  S P Bach; J Hill; J R T Monson; J N L Simson; L Lane; A Merrie; B Warren; N J McC Mortensen
Journal:  Br J Surg       Date:  2009-03       Impact factor: 6.939

8.  Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment.

Authors:  Miranda Kusters; Fabian A Holman; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Hetty A van den Berg; Adriaan J van den Brule; Cornelis J H van de Velde; Harm J T Rutten
Journal:  Radiother Oncol       Date:  2009-03-30       Impact factor: 6.280

9.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

10.  Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.

Authors:  Phil Quirke; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Jean Couture; Chris O'Callaghan; Arthur Sun Myint; Eric Bessell; Lindsay C Thompson; Mahesh Parmar; Richard J Stephens; David Sebag-Montefiore
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

View more
  25 in total

Review 1.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Modified simultaneous integrated boost radiotherapy for an unresectable huge refractory pelvic tumor diagnosed as a rectal adenocarcinoma.

Authors:  Takuma Nomiya; Hiroko Akamatsu; Mayumi Harada; Ibuki Ota; Yasuhito Hagiwara; Mayumi Ichikawa; Misako Miwa; Shouhei Kawashiro; Motohisa Hagiwara; Masahiro Chin; Eiji Hashizume; Kenji Nemoto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.

Authors:  J H Marks; G A Montenegro; J F Salem; M V Shields; G J Marks
Journal:  Tech Coloproctol       Date:  2016-05-13       Impact factor: 3.781

4.  Intensity-modulated radiation therapy for pelvic oligo-recurrence from rectal cancer: long-term results from a single institution.

Authors:  Xiang-Gao Zhu; Yong-Heng Li; Xiao-Fan Li; Yong Cai
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 5.  Locally advanced rectal cancer: the importance of a multidisciplinary approach.

Authors:  Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Francesca Morgese; Mariangela Torniai; Michela Tiberi; Consuelo Ferrini; Stefano Cascinu
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.

Authors:  Takehito Yamamoto; Kenji Kawada; Koya Hida; Riki Ganeko; Susumu Inamoto; Mami Yoshitomi; Takeshi Watanabe; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2019-02-05       Impact factor: 3.402

Review 7.  Locally Recurrent Rectal Cancer According to a Standardized MRI Classification System: A Systematic Review of the Literature.

Authors:  Zena Rokan; Constantinos Simillis; Christos Kontovounisios; Brendan Moran; Paris Tekkis; Gina Brown
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

8.  Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment.

Authors:  Jun Zhao; Chang-Zheng Du; Ying-Shi Sun; Jin Gu
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.

Authors:  Carolina González-Abós; F Borja de Lacy; Yoelimar Guzmán; Sara T Nogueira; Ana Otero-Piñeiro; Raúl Almenara; Antonio M Lacy
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584

10.  Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.

Authors:  Rosa M Jimenez-Rodriguez; Jonathan B Yuval; Charles-Etienne Gabriel Sauve; Isaac Wasserman; Piyush Aggarwal; Paul B Romesser; Christopher H Crane; Rona Yaeger; Andrea Cercek; Jose G Guillem; Martin R Weiser; Iris H Wei; Maria Widmar; Garrett M Nash; Emmanouil P Pappou; Julio Garcia-Aguilar; Marc J Gollub; Philip B Paty; J Joshua Smith
Journal:  Int J Colorectal Dis       Date:  2021-07-22       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.